China Revises Biopharma Rules Effective May 15 to Spur Innovation
China's government unveiled revised drug clinical trial regulations set to take effect May 15, aiming to accelerate reviews and foster biopharmaceutical innovation. The new rules ban trial sponsors from charging subjects fees and mandate full traceability of clinical data.